Palvella Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Palvella Therapeutics Inc
CIK #0001583648, 0001742961
EDGAR Form CIK 2011 - 2026
10-K [0001583648]
10-Q [0001583648]
3 [0001583648]
4 [0001583648]
8-K [0001583648]
D [0001583648]
SC 13D [0001583648]
SC 13G [0001583648]
D [0001742961]
Form 13D/13G Filer Form 13D/13G Subject Filed
First Light Asset Management LLC Palvella Therapeutics Inc [2026-02-17]
Frazier Life Sciences Public Fund LP Palvella Therapeutics Inc [2025-01-08]
Kaupinen WES Palvella Therapeutics Inc [2024-12-20]
Suvretta Capital Management LLC Palvella Therapeutics Inc [2024-12-20]
Samsara Biocapital LP Palvella Therapeutics Inc [2024-12-20]
Dellora Investments LP Pieris Pharmaceuticals Inc [2024-08-07]
ADAR1 Capital Management LLC Pieris Pharmaceuticals Inc [2024-08-01]
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2024-05-17]
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2024-05-17]
Checkpoint Capital LP Pieris Pharmaceuticals Inc [2023-06-12]
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2023-05-22]
Soleus Capital Master Fund LP Pieris Pharmaceuticals Inc [2023-01-27]
Lynx1 Capital Management LP Pieris Pharmaceuticals Inc [2022-10-24]
Soleus Capital Master Fund LP Pieris Pharmaceuticals Inc [2022-01-27]
Citadel Advisors LLC Pieris Pharmaceuticals Inc [2021-07-06]
Astrazeneca PLC Pieris Pharmaceuticals Inc [2021-04-08]
Seagen Inc Pieris Pharmaceuticals Inc [2021-04-02]
Nussbaum Ran Pieris Pharmaceuticals Inc [2021-02-16]
BlackRock Inc Pieris Pharmaceuticals Inc [2020-02-07]
EcoR1 Capital LLC Pieris Pharmaceuticals Inc [2019-11-14]
Aquilo Capital Management LLC Pieris Pharmaceuticals Inc [2019-10-07]
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2016-06-17]
Lombard Odier Asset Management USA Corp Pieris Pharmaceuticals Inc [2016-02-16]
Tekla Capital Management LLC Pieris Pharmaceuticals Inc [2016-02-12]
Novo Nordisk A S Pieris Pharmaceuticals Inc [2016-01-28]
Global Life Bioventure IV SARL Pieris Pharmaceuticals Inc [2015-09-11]
Tompkins Mark N Pieris Pharmaceuticals Inc [2015-07-10]
OrbiMed Advisors LLC Pieris Pharmaceuticals Inc [2015-07-09]
Form 3/4/5 Subject 2011 - 2026
Palvella Therapeutics Inc
Pauls Matthew
Goin Kathleen
Korenberg Matthew E
Davis Todd C
Heron Elaine J
Doux John
Kiritsy Christopher P
Wessel Tadd S
Jenkins George M
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Palvella Therapeutics Inc PVLA
Common Stock
2026-03-18 Option exercise 2,148 $9.08 19,504
Palvella Therapeutics Inc PVLA
Common Stock
2026-03-18 Sell 1,730 $118.37 204,780
Palvella Therapeutics Inc PVLA
Common Stock
2026-03-18 Sell 304 $119.08 36,200
Palvella Therapeutics Inc PVLA
Common Stock
2026-03-18 Option exercise 2,154 $7.14 15,380
Palvella Therapeutics Inc PVLA
Stock Option (Right to Buy) · derivative
2026-03-18 Option exercise 2,148 $0.00
Palvella Therapeutics Inc PVLA
Stock Option (Right to Buy) · derivative
2026-03-18 Option exercise 2,154 $0.00
Palvella Therapeutics Inc PVLA
Common Stock
2026-03-18 Sell 2,268 $117.56 266,626
Palvella Therapeutics Inc PVLA
Common Stock
2026-02-27 Buy 4,000 $125.00 500,000
Palvella Therapeutics Inc PVLA
Common Stock
2026-02-27 Buy 2,400 $125.00 300,000
Palvella Therapeutics Inc PVLA
Stock Option (Right to Buy) · derivative
2026-02-18 Option exercise 2,148 $0.00
Palvella Therapeutics Inc PVLA
Common Stock
2026-02-18 Sell 3,026 $79.16 239,538
Palvella Therapeutics Inc PVLA
Common Stock
2026-02-18 Option exercise 2,148 $9.08 19,504
Palvella Therapeutics Inc PVLA
Common Stock
2026-02-18 Option exercise 2,154 $7.14 15,380
Palvella Therapeutics Inc PVLA
Common Stock
2026-02-18 Sell 1,276 $79.97 102,042
Palvella Therapeutics Inc PVLA
Stock Option (Right to Buy) · derivative
2026-02-18 Option exercise 2,154 $0.00
Palvella Therapeutics Inc PVLA
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 38,517 $0.00
Palvella Therapeutics Inc PVLA
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 124,603 $0.00
Palvella Therapeutics Inc PVLA
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 44,123 $0.00
Palvella Therapeutics Inc PVLA
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 48,956 $0.00
Palvella Therapeutics Inc PVLA
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 64,318 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com